Bio-Techne Corp (TECH)
49.01 x 1 50.21 x 2
Pre-market by (Cboe BZX)
50.50 +0.25 (+0.50%) 04/29/25 [NASDAQ]
49.01 x 1 50.21 x 2
Pre-market 50.04 -0.46 (-0.91%) 08:46 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | TECH | ROIV | RGEN | ||
| Company | Bio-Techne Corp | Roivant Sciences Ltd | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 50.04 | 11.22 | 135.15 | ||
| High | 50.04 | 11.22 | 145.47 | ||
| Low | 50.04 | 11.22 | 132.46 | ||
| Last | 50.04 | 11.22 | 139.43 | ||
| Change | -0.46 | -0.07 | -4.20 | ||
| % Change | -0.91% | -0.62% | -2.92% | ||
| Volume | 897 | 474 | 1,991,100 | ||
| 20-Day Average Volume | 2,222,550 | 7,213,654 | 1,007,640 | ||
| Previous Close | 50.50 | 11.29 | 143.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.02 | 10.23 | 129.05 | ||
| 20-Day Raw Stochastic | 31.91% | 93.26% | 79.32% | ||
| 20-Day Relative Strength | 39.64% | 60.07% | 51.24% | ||
| Weighted Alpha | -41.27 | -0.90 | -14.52 | ||
| Today's Opinion | 100% Sell | 24% Sell | 64% Sell | ||
| Previous Opinion | 100% Sell | 8% Sell | 48% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.24% since 04/23/25 | +4.47% since 04/23/25 | +0.36% since 04/22/25 | ||
| Low | 49.15 on 04/25/25 | 10.77 on 04/24/25 | 132.46 on 04/29/25 | ||
| High | 51.99 on 04/24/25 | 11.40 on 04/29/25 | 148.94 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -14.80% since 03/28/25 | +8.09% since 03/28/25 | +4.51% since 03/28/25 | ||
| Low | 46.01 on 04/21/25 | 8.73 on 04/07/25 | 102.96 on 04/07/25 | ||
| High | 59.21 on 03/31/25 | 11.40 on 04/29/25 | 148.94 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -31.23% since 01/30/25 | -1.32% since 01/30/25 | -17.69% since 01/29/25 | ||
| Low | 46.01 on 04/21/25 | 8.73 on 04/07/25 | 102.96 on 04/07/25 | ||
| High | 79.28 on 02/05/25 | 11.51 on 02/10/25 | 177.17 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | -34.18% since 10/30/24 | -4.75% since 10/30/24 | +3.38% since 10/29/24 | ||
| Low | 46.01 on 04/21/25 | 8.73 on 04/07/25 | 102.96 on 04/07/25 | ||
| High | 80.80 on 11/06/24 | 12.94 on 11/25/24 | 182.52 on 01/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,983,444 | 8,055,968 | 7,828,853 | ||
| Shares Outstanding, K | 158,088 | 713,549 | 56,149 | ||
| Annual Sales | 1,159,060,000 | 124,800,000 | 634,440,000 | ||
| Annual Net Income | 168,110,000 | 4,348,930,000 | -25,510,000 | ||
| Last Quarter Sales | 297,030,000 | 9,020,000 | 174,150,000 | ||
| Last Quarter Net Income | 34,890,000 | 169,380,000 | -30,280,000 | ||
| 60-Month Beta | 1.45 | 1.25 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 02/05/25 | -0.13 on 02/10/25 | 0.39 on 04/29/25 | ||
| Latest Earnings Date | 05/07/25 | 05/29/25 | 04/29/25 | ||
| Most Recent Dividend | 0.080 on 02/14/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 02/14/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 30.45 | 0.00 | 97.05 | ||